Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura

Blood

Volumn 98, Issue 1, 2001, Pages 130-139

  Kuwana, Masataka ^a,b,c,d   Kaburaki, Junichi ^a,b,c,d   Kitasato, Hidero ^a,b,c,d   Kato, Miyako ^a,b,c,d   Kawai, Shinichi ^a,b,c,d   Kawakami, Yutaka ^a,b,c,d   Ikeda, Yasuo ^a,b,c,d  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO ELECTRIC POWER COMPANY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CORTICOSTEROID; CYTOKINE; DANAZOL; EPITOPE; FIBRINOGEN RECEPTOR; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 6; RECOMBINANT PROTEIN; TETANUS TOXOID; VINCRISTINE;

ADULT; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENECTOMY; T LYMPHOCYTE; THROMBOCYTOPENIC PURPURA;

EID: 0035412364     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.1.130     Document Type: Article

References (42)

1. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med. 1981;304:1135-1147.
2. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997;349:1531-1536.
3. Van Leeuwen EF, van der Ven JTM, Engelfriet CP, von dem Borne AEGK. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood. 1982;59:23-26.
4. He R, Reid DM, Jones CE, Shulman NR. 1994. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood. 1994;83:1024-1032.
5. Hürlmann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol. 1997;98:328-335.
6. Clavete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemost. 1994;72:1-15.
7. Borkowsky W, Karpatkin S. Leukocyte migration inhibition of buffy coats from patients with autoimmune thrombocytopenic purpura when exposed to normal platelets: modulation by transfer factor. Blood. 1984;63:83-87.
8. Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood. 1991;78:2619-2625.
9. Semple JW, Milev Y, Cosgrave D, et al. Difference in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 1996;87:4245-4254.
10. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of antiplatelet autoantibody. J Clin Invest. 1998;102:1393-1402.
11. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 1995;80:695-705.
12. Nishimura Y, Oiso M, Fujisao S, Kanai T, Chen Y, Matsushita S. Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases. Intern Rev Immunol. 1998;17:229-262.
13. Inoko H, Ota M. PCR-RFLP. In: Hui KM, Bidwell JL, eds. Handbook of HLA Typing Techniques. Boca Raton, FL: CRC Press; 1993:9-70.
14. Kuwana M, Kaburaki J, Pandey JP, et al. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura: associations with antiplatelet glycoprotein antibodies and responses to splenectomy. Tissue Antigens. 2000;56:337-343.
15. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 1988;67:31-40.
16. Takeda Y, Wang GS, Wang RJ, et al. Enzymelinked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol. 1989;50:213-230.
17. Kuwana M, Medsger TA Jr, Wright TM. Highly restricted TCR αβ usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol. 1997;158:485-491.
18. Kuwana M, Medsger TAJr, Wright TM. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest. 1995;96:586-596.
19. Kuwana M, Medsger TA Jr, Wright TM. Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive cells. J Immunol. 2000;164:6138-6146.
20. Nardi MA, Liu L-X, Karpatkin S. GPIIIa (49-66) is a major pathophysiologically relevant antigenic determinant for antiplatelet GPIIIa of HIV-1-related immunologic thrombocytopenia (HIV-1-ITP). Proc Natl Acad Sci U S A. 1997;94:7589-7594.
21. Nardi M, Karpatkin S. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med. 2000;191:2093-2100.
22. Filion MC, Proulx C, Bradley AJ, et al. Presence in peripheral blood of healthy donors of autoreactive T cells to a membrane antigen present on bone marrow-derived cells. Blood. 1996;88:2144-2150.
23. Kuwana M, Medsger TA Jr, Wright TM. T-B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J Immunol. 1995;155:2703-2714.
24. Hattori N, Kuwana M, Kaburaki J, Mimori T, Ikeda Y, Kawakami Y. T cells that are autoreactive to β2-glycoprotein I in patients with antiphospholipid syndrome and healthy donors. Arthritis Rheum. 2000;43:65-75.
25. Kekomaki R, Qawson B, McFarland J, Kunicki TJ. Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa. J Clin Invest. 1991;88:847-854.
26. Fujisawa K, O'Toole TE, Tani P, et al. Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura. Blood. 1991;77:2207-2213.
27. a alloantigen. Br J Haematol. 1989;71:77-83.
28. 235. J Autoimmun. 1991;4:415-431.
29. Fujisawa K, Tani P, McMillan R. Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens. Blood. 1993;81:1284-1289.
30. Bowditch RD, Tani P, McMillan R. Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides. Br J Haematol. 1995;91:178-184.
31. Kosugi S, Tomiyama Y, Shiraga M, et al. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies. Thromb Haemost. 1996;75:339-345.
32. Escher R, Muller D, Vogel M, Miescher S, Stadler BM, Berchtold P. Recombinant human natural autoantibodies against GPIIb-IIIa inhibit binding of autoantibodies from patients with AITP. Br J Haematol. 1998;102:820-828.
33. IIb, most commonly between amino acid F223 and Q459 [abstract]. Blood. 2000;96:814.
34. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today. 1993;14:203-208.
35. Dong, X, Hamilton KJ, Satoh M, Wang J, Reeves WH. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med. 1994;179:1243-1252.
36. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med. 1995;181:1945-1948.
37. Mamula MJ. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J Exp Med. 1993;177:567-571.
38. Lazarus R, McDowell RS. Structural and functional aspects of RDG-containing protein antagonists of glycoprotein IIb-IIIa. Curr Opin Biotech. 1993;4:438-445.
39. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 1992:358:155-157.
40. Craft J, Fatenejad S. Self-antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum. 1997;40:1374-1382.
41. Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899-909.
42. Kuwana M, Kaburaki J, Mimori T, Kawakami Y, Tojo T. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Arthritis Rheum. 2000;43:1074-1084.